Edition:
United States

People: Arrowhead Pharmaceuticals Inc (ARWR.OQ)

ARWR.OQ on NASDAQ Stock Exchange Global Select Market

13.62USD
3:59pm EST
Change (% chg)

$-0.04 (-0.29%)
Prev Close
$13.66
Open
$13.85
Day's High
$13.97
Day's Low
$13.59
Volume
387,451
Avg. Vol
646,176
52-wk High
$22.38
52-wk Low
$3.01

Waddill, William 

Mr. William D. Waddill is an Independent Director of Arrowhead Pharmaceuticals Inc, effective January 1, 2018. William Waddill began his career 30 years ago in commercial banking and public accounting and has been in the biotechnology industry for over 25 years. Currently, he is on the board of Protagonist Therapeutics and most recently was Senior Vice President and CFO of Calithera Bioscience. Prior to Calithera, Mr. Waddill was Senior Vice President and CFO at OncoMed Pharmaceuticals from 2007 to 2014. Mr. Waddill served as the Senior Vice President and CFO of Ilypsa, Inc., a biotechnology company that was acquired in 2007 by Amgen, Inc. Before joining Ilypsa, he served as the founder and principal at Square One Finance, a financial consulting business, and Mr. Waddill served as Senior Director of Finance and Administration at Exelixis, Inc., a biotechnology company. Mr. Waddill received a BS in accounting from the University of Illinois, Chicago, and certification as a public accountant (inactive) after working at PriceWaterhouseCoopers and Deloitte in Boston. Mr. Waddill’s qualifications to serve on the Board include his extensive background in the biopharma industry, his financial expertise, executive leadership roles and experience as a director of other public companies.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Douglass Given

201,813

Christopher Anzalone

1,871,210

Kenneth Myszkowski

725,371

Bruce Given

1,384,190

Zhen Li

--

Patrick O'Brien

804,990
As Of  29 Sep 2017